Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-18

Clinical Trial Update: Sitagliptin in the Elderly [Phase 2]

View source ↗

Summary

Phase 2 trial update for sitagliptin in elderly patients with type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sitagliptin (sitagliptin)

Snippet

Sponsor: University of British Columbia | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED